Publications

  1. Madan, M., Patel, A., Skruber, K., Geerts, D., Altomare, D.A., Phanstiel, O., IV. ATP13A3 and Caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers. Am. J. Cancer Res., 6(6):1231-1252, 2016.

  2. Oyer, J.L., Pandey, V., Igarashi, R.Y., Somanchi, S., Zakari, A., Solh, M., Lee, D., Altomare, D., Copik, A.  NK cells stimulated with PM21 particles expand and biodistribute in vivo: clinical implications for cancer treatment. Cytotherapy, 18(5):653-663, 2016. doi: 10.1016/j.jcyt.2016.02.006. PMID: 27059202.

  3. Pandey, V., Oyer, J.L., Igarashi, R.Y., Gitto, S.B., Copik, A.J., Altomare, D.A. Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells. Oncotarget, 7(6):7318-7328, 2016 doi: 10.18632/oncotarget.6939 PMID: 26802025

  4. Albury-Warren, T.M., Pandey, V., Spinel, L.P., Masternak, M.M., Altomare, D.A. Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1. Journal of Endocrinology, 228(1):49-59, 2016. PMID: 26487674

  5. Gitto, S.B. & Altomare, D.A. Recent insights into the pathophysiology of mTOR pathway dysregulation. Rep. Biol., 2015(6):1—16, 2015. http://www.dovepress.com/articles.php?article_id=20177 (Invited review)

  6. Albury, T.M., Pandey, V., Gitto, S.B., Dominguez, L., Spinel, L.P., Talarchek, J., Klein-Szanto, A.J., Testa, J.R., Altomare, D.A. Constitutive activation of Akt1 cooperates with KRasG12D to accelerate in vivo pancreatic tumor onset and progression. Neoplasia, 17(2), 175-182, 2015. PMID: 25748236 PMCID: PMC4351297

  7. Oyer, J.L., Igarashi, R.Y., Colosimo, D.A., Solh, M.M., Zakari, A., Khaled, Y.A., Altomare, D.A., Copik, A.J. Generation of highly cytotoxic Natural Killer cells for treatment of AML using feeder-free, particle based approach. Blood Marrow Transplant., Jan 6, 2015. PMID: 25576425

  8. Wiesenborn, D.S., Menon, V., Zhi, X., Do, A., Gesing, A., Wang, Z., Bartke, A., Altomare, D.A., Masternak, M.M. The effect of calorie restriction on insulin signaling in skeletal muscle and adipose tissue in Ames dwarf mice. Aging, 6(10):900-912, 2014. PMID: 25411241 PMCID: PMC4247389

  9. Muth, A., Pandey, V., Kaur, N., Wason, M., Baker, C., Han, X., Altomare, D.A., Phanstiel, O. IV. Synthesis and biological evaluation of anti-metastatic agents predicated upon Dihydromotuporamine C and its carboxyclic derivatives. Med. Chem., 57(10), 4023-4034, 2014. PMID: 24784222

  10. Menges, C.W., Kadariya, Y., Altomare, D., Talarchek, J., Neumann-Domer, E., Wu, Y., Xiao, G.-H., Shapiro, I., Kolev, V.N., Pachter, J.A., Klein-Szanto, A.J., Testa, J.R. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Cancer Res., 74(4), 1261-1271, 2014. PMID: 24371224 PMCID: PMC3079727

  11. Altomare, D.A., Khaled, A.R. Homeostasis and the importance for a balance between Akt/mTOR activity and intracellular signaling, Current Medicinal Chemistry, 19(22), 3748-3762, 2012. PMID: 22680924 PMCID: PMC3414727 (DAA corresponding author)

  12. Altomare, D.A., Menges, C.W., Xu, J., Pei, J., Zhang, L., Tadevosyan, A., Neumann-Domer, E., Liu, Z., Carbone, M., Chudoba, I., Klein-Szanto, A.J., Testa, J.R. Loss of Ink4a and Arf each contributes to increased susceptibility to asbestos-induced malignant mesothelioma development. PLoS One 6:e18828, 2011. PMID: 21526190 PMCID: PMC3079727

 

Complete list of Published Work in My Bibliography:
http://www.ncbi.nlm.nih.gov/myncbi/deborah.altomare.1/bibliography/40856696/public/?sort=date&direction=ascending